Business Description
Organogenesis Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US68621F1021
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.88 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | 8.88 | |||||
Interest Coverage | 4.76 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.64 | |||||
Beneish M-Score | -2.3 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.4 | |||||
3-Year EBITDA Growth Rate | -6.7 | |||||
3-Year EPS without NRI Growth Rate | -32.5 | |||||
3-Year Book Growth Rate | 24.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.23 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 20.73 | |||||
9-Day RSI | 29.58 | |||||
14-Day RSI | 36.75 | |||||
6-1 Month Momentum % | 62.28 | |||||
12-1 Month Momentum % | 6.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.09 | |||||
Quick Ratio | 2.74 | |||||
Cash Ratio | 1.22 | |||||
Days Inventory | 89.43 | |||||
Days Sales Outstanding | 76.14 | |||||
Days Payable | 87.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | 2.46 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.29 | |||||
Operating Margin % | 2.2 | |||||
Net Margin % | -1.62 | |||||
FCF Margin % | 0.83 | |||||
ROE % | -2.68 | |||||
ROA % | -1.63 | |||||
ROIC % | 1.55 | |||||
ROC (Joel Greenblatt) % | -5.84 | |||||
ROCE % | -3.42 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 207.14 | |||||
PE Ratio without NRI | 44.17 | |||||
PS Ratio | 0.93 | |||||
PB Ratio | 1.51 | |||||
Price-to-Tangible-Book | 1.79 | |||||
Price-to-Free-Cash-Flow | 109.66 | |||||
Price-to-Operating-Cash-Flow | 30.58 | |||||
EV-to-EBIT | -32.41 | |||||
EV-to-Forward-EBIT | 5.05 | |||||
EV-to-EBITDA | 34.08 | |||||
EV-to-Forward-EBITDA | 4.15 | |||||
EV-to-Revenue | 0.91 | |||||
EV-to-Forward-Revenue | 0.78 | |||||
EV-to-FCF | 106.2 | |||||
Price-to-Projected-FCF | 3.63 | |||||
Price-to-Graham-Number | 1.87 | |||||
Price-to-Net-Current-Asset-Value | 6.04 | |||||
Earnings Yield (Greenblatt) % | -3.09 | |||||
FCF Yield % | 0.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Organogenesis Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 417.319 | ||
EPS (TTM) (€) | -0.062 | ||
Beta | 1.12 | ||
Volatility % | 87.31 | ||
14-Day RSI | 36.75 | ||
14-Day ATR (€) | 0.170518 | ||
20-Day SMA (€) | 3.445 | ||
12-1 Month Momentum % | 6.32 | ||
52-Week Range (€) | 2.06 - 4.24 | ||
Shares Outstanding (Mil) | 125.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Organogenesis Holdings Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Organogenesis Holdings Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Organogenesis Holdings Inc Frequently Asked Questions
What is Organogenesis Holdings Inc(FRA:2PQ)'s stock price today?
When is next earnings date of Organogenesis Holdings Inc(FRA:2PQ)?
Does Organogenesis Holdings Inc(FRA:2PQ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |